activins has been researched along with Osteoporosis, Postmenopausal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasilakis, AD; Kalra, B; Kumar, A; Makras, P; Mantzoros, CS; Polyzos, SA; Rodopaios, NE | 1 |
| Anastasilakis, AD; Anastasilakis, DA; Kalra, B; Kumar, A; Makras, P; Mantzoros, CS; Polyzos, SA; Sarridimitriou, A; Savvidis, M | 1 |
| Anastasilakis, AD; Gkiomisi, A; Makras, P; Papatheodorou, A; Polyzos, SA; Savvides, M; Terpos, E | 1 |
3 other study(ies) available for activins and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study.
Topics: Activins; Case-Control Studies; Female; Follistatin; Follistatin-Related Proteins; Glycoproteins; Humans; Inhibins; Osteoporosis, Postmenopausal | 2023 |
Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study.
Topics: Activins; Case-Control Studies; Female; Follistatin; Glycoproteins; Humans; Inhibins; Osteoporosis, Postmenopausal | 2023 |
Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment.
Topics: Activins; Age Factors; Aged; Aging; Biomarkers; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Female; Femur Neck; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Zoledronic Acid | 2013 |